(Q36725230)

15 August 2017

1 reference

title

In silico approaches to explore toxicity end points: issues and concerns for estimating human health effects (English)

1 reference

15 August 2017

1 reference

Edwin J Matthews

1

1 reference

15 August 2017

Joseph F Contrera

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Expert Opinion on Drug Metabolism & Toxicology

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

125-134

1 reference

Use of toxicological information in drug design

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

QSAR modeling of carcinogenic risk using discriminant analysis and topological molecular descriptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

Use of dual control groups to estimate false positive rates in laboratory animal carcinogenicity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

U.S. EPA regulatory perspectives on the use of QSAR for new and existing chemical evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.125

Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1177/026119290503300209

18 January 2024

Identifiers

DOI

10.1517/17425255.3.1.125

1 reference

15 August 2017

1 reference